Correction: Natural killer cell infiltration in prostate cancers predict improved patient outcomes

Affiliations

¹ Masonic Cancer Center, University of Minnesota-Twin Cities, Minneapolis, MN, USA. zorko004@umn.edu.
² Masonic Cancer Center, University of Minnesota-Twin Cities, Minneapolis, MN, USA.
³ Caris Life Sciences, Phoenix, AZ, USA.
⁴ University Hospital Seidman Cancer Center, Cleveland, OH, USA.
⁵ Holden Comprehensive Cancer Center, Iowa City, IA, USA.
⁶ Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
⁷ Herbert Irving Comprehensive Cancer Center, Columbia University New York, New York, NY, USA.
⁸ Sidney Kimmel Cancer Center, Jefferson Medical College, Philadelphia, PA, USA.
⁹ University of Chicago Medicine Comprehensive Cancer Center, Chicago, IL, USA.
¹⁰ Winship Cancer Institute of Emory University, Atlanta, GA, USA.
¹¹ Legorreta Cancer Center, Brown University, Providence, RI, USA.
¹² Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA.
¹³ Saint John's Cancer Institute, Saint John's Health Center PHS, Santa Monica, CA, USA.

^# Contributed equally.

Published Erratum

Nicholas A Zorko et al. Prostate Cancer Prostatic Dis. 2025.

. 2025 Aug 12.

doi: 10.1038/s41391-025-01009-z. Online ahead of print.

¹ Masonic Cancer Center, University of Minnesota-Twin Cities, Minneapolis, MN, USA. zorko004@umn.edu.
² Masonic Cancer Center, University of Minnesota-Twin Cities, Minneapolis, MN, USA.
³ Caris Life Sciences, Phoenix, AZ, USA.
⁴ University Hospital Seidman Cancer Center, Cleveland, OH, USA.
⁵ Holden Comprehensive Cancer Center, Iowa City, IA, USA.
⁶ Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
⁷ Herbert Irving Comprehensive Cancer Center, Columbia University New York, New York, NY, USA.
⁸ Sidney Kimmel Cancer Center, Jefferson Medical College, Philadelphia, PA, USA.
⁹ University of Chicago Medicine Comprehensive Cancer Center, Chicago, IL, USA.
¹⁰ Winship Cancer Institute of Emory University, Atlanta, GA, USA.
¹¹ Legorreta Cancer Center, Brown University, Providence, RI, USA.
¹² Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA.
¹³ Saint John's Cancer Institute, Saint John's Health Center PHS, Santa Monica, CA, USA.

^# Contributed equally.

No abstract available

Erratum for

Natural Killer Cell Infiltration in Prostate Cancers Predict Improved Patient Outcomes.
Zorko NA, Makovec A, Elliott A, Kellen S, Lozada JR, Arafa AT, Felices M, Shackelford M, Barata P, Zakharia Y, Narayan V, Stein MN, Zarrabi KK, Patnaik A, Bilen MA, Radovich M, Sledge G, El-Deiry WS, Heath EI, Hoon DSB, Nabhan C, Miller JS, Hwang JH, Antonarakis ES. Zorko NA, et al. Prostate Cancer Prostatic Dis. 2025 Mar;28(1):129-137. doi: 10.1038/s41391-024-00797-0. Epub 2024 Feb 28. Prostate Cancer Prostatic Dis. 2025. PMID: 38418892 Free PMC article.